TAKAYASU ARTERITIS (TAK)

Clinical trials for TAKAYASU ARTERITIS (TAK) explained in plain language.

Never miss a new study

Get alerted when new TAKAYASU ARTERITIS (TAK) trials appear

Sign up with your email to follow new studies for TAKAYASU ARTERITIS (TAK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for rare vascular disease: trial tests two experimental drugs

Disease control Not yet recruiting

This study compares two new drugs, vunakizumab and ivarmacitinib, against standard steroid treatment for adults with active Takayasu's arteritis, a rare inflammatory disease of the blood vessels. Researchers will enroll 180 participants across multiple centers to see which treatm…

Matched conditions: TAKAYASU ARTERITIS (TAK)

Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

TAKAYASU ARTERITIS (TAK)

Get alerted when new TAKAYASU ARTERITIS (TAK) trials appear

New hope for rare vascular disease: trial tests two experimental drugs